{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:27:12Z","timestamp":1789129632443,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ctro.2026.101266","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:28:04Z","timestamp":1787239684000},"page":"101266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["De-escalated total neoadjuvant therapy for the non-operative management of rectal cancer: Results of the NOM-3\/TNT prospective cohort study"],"prefix":"10.1016","volume":"61","author":[{"given":"Bart\u0142omiej","family":"Skrzypiec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Paciorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucyna","family":"Pietrzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"\u017b\u00f3\u0142ciak-Siwi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142 F.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Wro\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ho\u0142dakowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Kapa\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Ta\u0142asiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Olesi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Bujko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101266_bb0005","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study","volume":"391","author":"van der Valk","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2026.101266_bb0010","doi-asserted-by":"crossref","first-page":"e230146","DOI":"10.1001\/jamasurg.2023.0146","article-title":"Long-term quality of life and functional outcome of patients with rectal cancer following a watch-and-wait approach","volume":"158","author":"Custers","year":"2023","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ctro.2026.101266_bb0015","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1470-2045(15)00467-2","article-title":"Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis","volume":"17","author":"Renehan","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101266_bb0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.radonc.2021.05.014","article-title":"Watch-and-wait strategy in rectal cancer: is there a tumour size limit? Results from two pooled prospective studies","volume":"160","author":"Jankowski","year":"2021","journal-title":"Radiother Oncol"},{"issue":"15","key":"10.1016\/j.ctro.2026.101266_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153665","article-title":"Morpheus phase II-III study: a pre-planned interim safety analysis and preliminary results","volume":"14","author":"Garant","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2026.101266_bb0030","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2468-1253(22)00392-2","article-title":"Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial","volume":"8","author":"Gerard","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ctro.2026.101266_bb0035","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1470-2045(15)00120-5","article-title":"High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study","volume":"16","author":"Appelt","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101266_bb0040","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy","volume":"40","author":"Garcia-Aguilar","year":"2022","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2026.101266_bb0045","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S2468-1253(25)00049-4","article-title":"Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO\/ARO\/AIO-16): an open-label, multicentre, single-arm, phase 2 trial","volume":"10","author":"Gani","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101266_bb0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejso.2017.11.010","article-title":"Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer?","volume":"44","author":"S\u00e3o Juli\u00e3o","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2026.101266_bb0055","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/SLA.0000000000005507","article-title":"Intentional watch and wait or organ preservation surgery following neoadjuvant chemoradiotherapy plus consolidation CAPEOX for MRI-defined low-risk rectal cancer: findings from a prospective phase 2 trial (PKUCH-R01 trial, NCT02860234)","volume":"277","author":"Wang","year":"2023","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ctro.2026.101266_bb0060","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ijrobp.2021.10.004","article-title":"Clinical complete response in patients with rectal adenocarcinoma treated with short-course radiation therapy and nonoperative management","volume":"112","author":"Chin","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2026.101266_bb0065","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ijc.70126","article-title":"Total neoadjuvant therapy in rectal cancer: the FOREST protocol, a patient-centered approach that clusters two cohorts with different outcomes","volume":"158","author":"Guadalajara","year":"2026","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctro.2026.101266_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110884","article-title":"Phase II trial of organ preservation program using short-course radiation and FOLFOXIRI for rectal cancer (SHORT-FOX): two-year primary outcome analysis","volume":"207","author":"Klebaner","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101266_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110960","article-title":"Endorectal high-dose-rate brachytherapy boost in rectal cancer: results of the prospective cohort NOM-3 study on the watch-and-wait strategy","volume":"209","author":"\u017b\u00f3\u0142ciak-Siwi\u0144ska","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101266_bb0080","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/jamasurg.2021.4566","article-title":"Association of delayed surgery with oncologic long-term outcomes in patients with locally advanced rectal cancer not responding to preoperative chemoradiation","volume":"156","author":"Deidda","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ctro.2026.101266_bb0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101266_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102796","article-title":"Oncological risks associated with the planned watch-and-wait strategy using total neoadjuvant treatment for rectal cancer: a narrative review","volume":"129","author":"Socha","year":"2024","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.ctro.2026.101266_bb0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/DCR.0000000000002494","volume":"66","author":"Fernandez","year":"2023","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ctro.2026.101266_bb0100","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1080\/0284186X.2023.2245553","article-title":"The ultimate local failure rate after the watch-and-wait strategy for rectal cancer: a systematic review of literature and meta-analysis","volume":"62","author":"Socha","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctro.2026.101266_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2019.10.009","article-title":"The risk of distant metastases in rectal cancer managed by a watch-and-wait strategy - a systematic review and meta-analysis","volume":"144","author":"Socha","year":"2020","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2026.101266_bb0110","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00330-017-5026-2","article-title":"Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting","volume":"28","author":"Beets-Tan","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ctro.2026.101266_bb0115","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/DCR.0b013e3181f42b89","article-title":"Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization","volume":"53","author":"Habr-Gama","year":"2010","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ctro.2026.101266_bb0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1245\/s10434-017-6213-8","article-title":"Organ preservation in rectal cancer after chemoradiation: should we extend the observation period in patients with a clinical near complete response?","volume":"25","author":"Hupkens","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctro.2026.101266_bb0125","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e31824f1c21","article-title":"Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer","volume":"255","author":"Emmertsen","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.ctro.2026.101266_bb0130","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1200\/JCO.1984.2.11.1281","article-title":"The importance of dose intensity in chemotherapy of metastatic breast cancer","volume":"2","author":"Hryniuk","year":"1984","journal-title":"J Clin Oncol"},{"issue":"Suppl. 3","key":"10.1016\/j.ctro.2026.101266_bb0135","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1245\/s10434-021-10432-0","article-title":"Does total neoadjuvant treatment improve overall survival in rectal cancer? No, it does not","volume":"28","author":"Socha","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctro.2026.101266_bb0140","doi-asserted-by":"crossref","first-page":"S1170","DOI":"10.1016\/S0167-8140(25)00493-1","article-title":"STAR-TREC (NCT02945566): a randomised phase II\/III trial of CRT versus 5x5 Gy SCRT for organ preservation in early\/intermediate risk rectal cancer","volume":"206","author":"Marijnen","year":"2025","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.ctro.2026.101266_bb0145","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.annonc.2024.07.729","article-title":"Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy","volume":"35","author":"Bercz","year":"2024","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2026.101266_bb0150","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s11605-023-05601-3","article-title":"Total neoadjuvant therapy in rectal Cancer: multi-center comparison of induction chemotherapy and long-course chemoradiation versus short-course radiation and consolidative chemotherapy","volume":"27","author":"Moyer","year":"2023","journal-title":"J Gastrointest Surg"},{"issue":"5","key":"10.1016\/j.ctro.2026.101266_bb0155","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/annonc\/mdw062","article-title":"Long-course oxaliplatin-based preoperative chemoradiation versus 5 \u00d7 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study","volume":"27","author":"Bujko","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctro.2026.101266_bb0160","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/DCR.0000000000001166","article-title":"Patient and physician preferences for nonoperative management for low rectal Cancer: is it a reasonable treatment option?","volume":"61","author":"Kennedy","year":"2018","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"10.1016\/j.ctro.2026.101266_bb0165","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1200\/JCO.23.01208","article-title":"Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA trial","volume":"42","author":"Verheij","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101266_bb0170","article-title":"Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): a phase I trial","volume":"60","author":"Eijkelenkamp","year":"2026","journal-title":"Clin Transl Radiat Oncol"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:24:12Z","timestamp":1789125852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826001618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":34,"alternative-id":["S2405630826001618"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101266","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De-escalated total neoadjuvant therapy for the non-operative management of rectal cancer: Results of the NOM-3\/TNT prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101266"}}